|
AU2740900A
|
|
Method of treating demyelinating inflammatory disease using ccr1 antagonists
|
|
AU1122300A
|
|
Pharmaceutical formulations useful to treat inflammatory and immune disorders
|
|
WO0001381A1
|
|
Substituted oxygen alicyclic compounds, including methods for synthesis thereof
|
|
WO0001683A1
|
|
Methods for synthesis of substituted tetrahydrofuran compound
|
|
AU2567599A
|
|
Anti-ccr1 antibodies and methods of use therefor
|
|
AU2335699A
|
|
Chemokine receptor antagonists and methods of use therefor
|
|
WO0014089A1
|
|
Chemokine receptor antagonists and methods of use therefor
|
|
WO9917796A2
|
|
Modulation of lerk-2-mediated cell adhesion
|
|
US6054579A
|
|
Synthesis of substituted lactams
|
|
CA2212702A1
|
|
Mucosal vascular addressins and uses thereof
|
|
US6037324A
|
|
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US6083903A
|
|
Boronic ester and acid compounds, synthesis and uses
|
